v3.26.1
Condensed Consolidated Statements of Income (Loss) (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Net sales $ 2,960 $ 2,810 $ 5,661 $ 5,435
Cost of sales 1,928 1,819 3,738 3,583
Gross margin 1,032 991 1,923 1,852
Selling, general and administrative expenses 735 718 1,463 1,421
Research and development expenses 129 134 268 274
Other operating income, net (49) (52) (91) (92)
Operating income 217 191 283 249
Interest expense, net 64 58 130 122
Other (income) expense, net (5) 0 1 (3)
Income (loss) from continuing operations before income taxes 158 133 152 130
Income tax expense (benefit) 23 11 34 (56)
Income (loss) from continuing operations 135 122 118 186
Income (loss) from discontinued operations, net of tax (9) (31) (7) 31
Net income (loss) 126 91 111 217
Net income attributable to noncontrolling interests 0 0 0 0
Net income (loss) attributable to Baxter stockholders $ 126 $ 91 $ 111 $ 217
Income (loss) from continuing operations per common share        
Income from continuing operations per common share, basic (in dollars per share) $ 0.26 $ 0.24 $ 0.23 $ 0.36
Income from continuing operations per common share, diluted (in dollars per share) 0.26 0.24 0.23 0.36
Income (loss) from discontinued operations per common share        
Income from discontinued operations per common share, basic (in dollars per share) (0.02) (0.06) (0.01) 0.06
Income from discontinued operations per common share, diluted (in dollars per share) (0.02) (0.06) (0.02) 0.06
Income (loss) per common share        
Basic (in dollars per share) 0.24 0.18 0.22 0.42
Diluted (in dollars per share) $ 0.24 $ 0.18 $ 0.21 $ 0.42
Weighted-average number of shares outstanding        
Basic (in shares) 517 513 516 512
Diluted (in shares) 518 514 517 514